Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	42.58	94.42	66.22
Graham Fair Price	-1.48	5.73	5.81
PEG	374.67	-4.28	0.90
Price/Book	36.74	5.87	4.30
Price/Cash Flow	-36.41	111.15	174.79
Prices/Earnings	57.13	29.51	18.78
Price/Sales	58.70	23.52	14.82
Price/FCF	-36.41	111.15	174.79
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	7.50	0.34	0.31
Operating Margin	22.77	0.23	0.19
ROA	-16.80	0.03	0.03
ROE	0.06	0.05	-12.98
ROIC	0.04	0.04	-2.52
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.15	0.18	-15.32
Dividends QOQ	-0.48	0.65	37.69
EBIT QOQ	< 0.005	0.12	1398.31
EPS QOQ	0.21	-0.07	-66.90
FCF QOQ	-0.44	1.27	190.92
Revenue QOQ	0.22	-0.09	-60.15
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	81.04	109.35	34.94
Days Sales Outstanding (DSO)	88.51	86.21	-2.61
Inventory Turnover	1.11	0.82	-25.89
Debt/Capitalization	0.23	0.25	6.61
Quick Ratio	1.21	0.98	-18.59
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.13	5.41	5.61
Cash	1.72	2.00	16.32
Capex	-0.15	-0.18	-21.00
Free Cash Flow	0.13	0.29	127.10
Revenue	1.49	1.35	-9.00
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.56	1.50	-4.17
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.34	-0.65	-51.42
Naive Interpretation	Member

06 - Financial Health · Weak

Rating